MENOSTAR (estradiol) by Bayer is estrogen receptor agonists [moa]. Approved for estrogen [epc]. First approved in 1994.
Drug data last refreshed 15h ago · AI intelligence enriched 1w ago
MENOSTAR is a transdermal estradiol patch delivering estrogen via extended-release film formulation, approved in 1994. It works as an estrogen receptor agonist to treat menopausal symptoms. The product addresses vasomotor symptoms and bone health in post-menopausal women.
Product is in late-stage lifecycle with moderate competitive pressure (60/100), signaling contracted or defensive commercial operations focused on retention rather than growth.
Estrogen Receptor Agonists
Estrogen
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Worked on MENOSTAR at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on MENOSTAR represents a defensive, operations-focused career assignment in a mature, genericizing market. This role emphasizes margin protection, managed care negotiation, and cost-containment skills rather than innovation or market expansion.